Prof. Heinrich Klech

MD, PhD,

Vienna Medical University. Director, PharmaTrain Federation.

Heinrich is an internal medicine specialist by training from the University of Vienna. He is author of more than 200 publications in the field of lung diseases and served on the editorial board of many renowned medical journals in the field of Pulmonology and Internal medicine After a successful academic international career he changed to executive R&D management positions in the pharmaceutical industry. He held position for Central Eastern Europe, Central Asia, Middle East and Africa for Eli Lilly & Company, and led later Lillys R+D and regulatory activities in a large part of Western Europe. He retired in 2008 from Lilly.

For decades he held responsibilities for postgraduate education on behalf of the Austrian medical association. In 2000 he founded the Vienna School for Clinical Research (VSCR), a not-for-profit postgraduate educational institution, which trained and developed clinical researchers on a global basis in close partnership with 14 international universities. The VSCR in collaboration with the Medical University Vienna (MUW) in the past 13 years has trained more than 6500 scientists from more than 100 countries.

He is a board member of various national and international pharmaceutical associations as well as postgraduate educational institutions. For the last 5 years he is also in a leading executive position within the European IMI (Innovative Medicine Initiative) projects, a joint project of the European Commission and EFPIA.